Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
D000230:Adenocarcinoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D000818:Animals; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D002417:Cattle; D002460:Cell Line; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005260:Female; D005620:Freund's Adjuvant; D005833:Genital Neoplasms, Female / Q000628:therapy; D006168:Guinea Pigs / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D007167:Immunotherapy; D066298:In Vitro Techniques; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D012313:RNA / Q000627:therapeutic use; D012260:Ribonucleases; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy
D000951:Antigens, Neoplasm; D000939:Epitopes; D007106:Immune Sera; D012313:RNA; D003165:Complement System Proteins; D005620:Freund's Adjuvant; D012260:Ribonucleases